Related Experiment Video
Updated: Jun 24, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
The Use of Long-term Antibiotics for Suppression of Bacterial Infections
Molly Horne1, Ian Woolley1,2, Jillian S Y Lau1,2
1Faculty of Medicine, Nursing, and Health Sciences, Monash University, Clayton, Victoria, Australia.
Abstract:
Suppressive antibiotic therapy is prescribed when a patient has an infection that is presumed to be incurable by a defined course of therapy or source control. The cohort receiving suppressive antibiotic therapy is typically highly comorbid and the infections often involve retained prosthetic material. In part due to a lack of clear guidelines regarding the use of suppressive antibiotics, and in part due to the complex nature of the infections in question, patients are often prescribed suppressive antibiotics for extremely long, if not indefinite, courses. The risks of prolonged antibiotic exposure in this context are not fully characterized, but they include adverse drug effects ranging from mild to severe, the development of antibiotic-resistant organisms, and perturbations of the gastrointestinal microbiome. In this narrative review we present the available evidence for the use of suppressive antibiotic therapy in 4 common indications, examine the gaps in the current literature, and explore the known and potential risks of this therapy. We also make suggestions for improving the quality of evidence in future studies, particularly by highlighting the need for a standardized term to describe the use of long courses of antibiotics to suppress hard-to-treat infections.
Insights
Suppressive antibiotic therapy is used for incurable infections, often with prosthetic material. This review examines its risks, including adverse effects and antibiotic resistance, and calls for standardized terminology for long-term use.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Suppressive antibiotic therapy is used for infections presumed incurable by standard treatment or source control.
- Patients often have comorbidities and retained prosthetic material, necessitating prolonged or indefinite antibiotic courses.
- Lack of clear guidelines contributes to extended antibiotic use, with poorly characterized risks.
Purpose of the Study:
- To review evidence for suppressive antibiotic therapy in four common indications.
- To identify gaps in the current literature regarding its use.
- To explore the known and potential risks associated with prolonged antibiotic exposure.
Main Methods:
- Narrative review of existing literature.
- Analysis of evidence for suppressive antibiotic therapy in specific clinical scenarios.
- Examination of risks, including adverse drug effects, antibiotic resistance, and microbiome disruption.
Main Results:
- Evidence for suppressive antibiotic therapy in four common indications was presented.
- Gaps in the current literature were identified.
- Known and potential risks of prolonged antibiotic exposure were explored.
Conclusions:
- Suppressive antibiotic therapy is a complex treatment for hard-to-treat infections.
- Further research is needed to fully characterize risks and optimize treatment strategies.
- A standardized term for long-term suppressive antibiotic use is recommended to improve evidence quality.
More Related Videos
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
07:44Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Tonsillitis II: Management